The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia
Open accessAbstract
Objective: The diagnostic value of the addition of alarm symptoms in distinguishing functional from organic gastrointestinal disease remains uncertain. We aimed to establish the value of alarm features in differentiating between organic disease and irritable bowel syndrome (IBS) and functional dyspepsia (FD). Methods: A total of 568 consecutive patients (63% female; mean age 44.7 years) completed a detailed symptom questionnaire and then received a complete diagnostic workup, as required. Questionnaire data were collected prospectively and audited retrospectively; the treating physician was blinded to the results of the questionnaires. Patients were coded and allocated to the following diagnostic groups: IBS, FD, organic diseases of the upper gastrointestinal tract, or organic diseases of the lower gastrointestinal tract. Logistic regression was used to identify the best subset of symptoms that discriminated organic disease from functional illness. Separate models compared IBS (n = 214) with diseases of the lower gastrointestinal tract (n = 66), and FD (n = 70) with diseases of the upper gastrointestinal tract (n = 250). Results: Age (50 years at symptom onset: odds ratio (OR) 2.65 (95% confidence interval 1.4–5.0); p = 0.002) and blood on the toilet paper (OR 2.7 (1.4–5.1);p = 0.002) emerged as alarm features that discriminated IBS from lower gastrointestinal illness. A diagnosis of IBS was typically associated with female sex (OR2.5 (1.3–4.6); p = 0.004), pain on six or more occasions in the previous year (OR 5.0 (2.2–11.1); p<0.001), pain that radiated outside of the abdomen (OR 2.9 (1.4–6.3); p = 0.006), and pain associated with looser bowel motions (OR 2.1 (1.1–4.2); p = 0.03). A model incorporating three Manning criteria and alarm features yielded a correct diagnosis of IBS in 96% and a correct diagnosis of organic disease in 52% of cases. Alarm features did not discriminate FD from upper gastrointestinal disease. Patients with FD were significantly more likely to report upper abdominal pain (OR 3.7 (1.7–8.3); p = 0.002) and significantly less likely to report aspirin use (OR 0.26 (0.1–0.6); p = 0.001). The predictive value of symptoms in diagnosing FD was only 17%. Conclusions: Symptoms plus alarm features have a high predictive value for diagnosing IBS but the predictive value for a diagnosis of FD remains poor. Current criteria for the diagnosis of IBS should incorporate relevant alarm features to improve the diagnostic yield.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Functional Gastroduodenal Disorders
Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418
Self-citationMedical costs in community subjects with irritable bowel syndrome
Talley, N. J., Gabriel, S. E., Harmsen, W. S., Zinsmeister, A. R., & Evans, R. W. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90738-6 · Cited by 460
Self-citation
Research works printed but not linked: 31
- 10.1016/S0140-6736(02)09712-X · DOI · Paper page
- 1995, Gastroenterology, 109, 2029, 10.1016/0016-5085(95)90773-4 · DOI
- 10.1053/gast.2002.33741 · DOI
- 1999, Gut, 45, II37
- 10.1001/archinte.161.17.2081 · DOI
- 1978, BMJ, 2, 653, 10.1136/bmj.2.6138.653 · DOI · Paper page
- 1984, Gastroenterology, 87, 1, 10.1016/0016-5085(84)90119-7 · DOI · Paper page
- 1992, Gastroenterol Int, 5, 75
- 10.1136/gut.31.1.77 · DOI · Paper page
- 1992, Eur J Gastroenterol Hepatol, 4, 747
- 1993, Korean J Intern Med, 8, 34, 10.3904/kjim.1993.8.1.34 · DOI
- 1996, Acta Gastroenterol Belg, 59, 225
- 10.1136/gut.25.10.1089 · DOI
- 10.1007/BF01308166 · DOI
- 10.1016/S0002-9343(99)00158-8 · DOI
- 1997, Scand J Gastroenterol, 32, 118, 10.3109/00365529709000181 · DOI
- 10.1097/00004836-200207000-00005 · DOI
- 10.1111/j.1572-0241.1999.01437.x · doi:10.1111/j.1572-0241.1999.01437.x · Paper page
- 10.1111/j.1572-0241.1998.00530.x · DOI
- 1989, Ann Intern Med, 111, 671, 10.7326/0003-4819-111-8-671 · DOI · Paper page
- 1992, Dig Dis Sci, 37, 164, 10.1007/BF01308166 · DOI
- 1994, Am J Gastroenterol, 89, 176
- 10.1053/gast.2002.34755 · DOI · Paper page
- 10.1080/00365520310000528 · doi:10.1080/00365520310000528
- 1997, Gut, 41, 513, 10.1136/gut.41.4.513 · doi:10.1136/gut.41.4.513
- 10.1111/j.1572-0241.1999.00774.x · doi:10.1111/j.1572-0241.1999.00774.x
- 10.1046/j.1365-2036.2000.00728.x · DOI
- 10.1080/003655202320378167 · DOI
- 10.1111/j.1572-0241.2002.05536.x · DOI
- 10.1136/gut.49.1.29 · DOI
- 2003, Endoscopy, 35, 61, 10.1055/s-2003-36414 · doi:10.1055/s-2003-36414
Cited by
Functional Gastroduodenal Disorders
Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418
Self-citationComponents of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 997
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015591 · Cited by 900
“[19,20] was confirmed by a board certified gastroenterologist (AJL) or a nurse practitioner (EF) experienced in functional bowel disorders.”
BackgroundGuidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Saha, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6759 · Cited by 500
Guidelines for the Management of Dyspepsia
Talley, N. J., Vakil, N., & the Practice Parameters Committee of the American College of Gastroenterology (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00225.x · Cited by 489
Self-citationAmerican Gastroenterological Association Technical Review on the Evaluation of Dyspepsia
Talley, N. J., Vakil, N. B., & Moayyedi, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.020 · Cited by 440
Self-citationAn Evidence-Based Systematic Review on the Management of Irritable Bowel Syndrome
Brandt, L. J., Chey, W. D., Foxx-Orenstein, A. E., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P. S., Spiegel, B. M., Talley, N. J., & Moayyedi, P. (2009) · American Journal of Gastroenterology · doi:10.14309/00000434-200901001-00002 · Cited by 225
Self-citationDyspepsia: Organic Versus Functional
Oustamanolakis, P., & Tack, J. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318241b335 · Cited by 146
Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome
WHITEHEAD, W. E., PALSSON, O. S., FELD, A. D., LEVY, R. L., VON KORFF, M., TURNER, M. J., & DROSSMAN, D. A. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02956.x · Cited by 118
Validation of Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome: A Critical Review
Whitehead, W. E., & Drossman, D. A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.56 · Cited by 114
Definition and Classification of Irritable Bowel Syndrome: Current Consensus and Controversies
Longstreth, G. F. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.02.011 · Cited by 95
Functional dyspepsia and gastroparesis: one disease or two
Lacy, B. E. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.104 · Cited by 66
Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 revised edition
Song, K. H., Jung, H.-K., Kim, H. J., Koo, H. S., Kwon, Y. H., Shin, H. D., Lim, H. C., Shin, J. E., Kim, S. E., Cho, D. H., et al. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm17145 · Cited by 47
“However, certain “alarm signs” (unexplained weight loss, blood in the stool, anemia, and a recent change in bowel habits) call for special consideration of other disorders before symptoms can be attributed to IBS.(18,27,31,32) In these cases, colonoscopy has diagnostic value, not only for excluding organic diseases su…”
Background(2009) · doi:10.4166/kjg.2019.73.2.84 · Cited by 11
Metadata
- Authors
- Hammer, J., Eslick, G. D., Howell, S. C., Altiparmak, E., & Talley, N. J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-04-13
- Volume
- 53
- Issue
- 5
- Pages
- 666-672
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2156138052
- Cited by
- 171
- References
- 3
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.